Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Thromb Res. 2020 Jan 7;187:9–17. doi: 10.1016/j.thromres.2020.01.002

Figure 1. Survival functions of overall survival according to dichotomized biomarkers.

Figure 1

y-axis: cumulative survival in percent (%), x-axis: overall survival (time from therapy initiation to death from any cause) in months; continuous line: survival function of patients with biomarker ≤75th percentile; dotted line: survival function of patients with biomarker >75th percentile; crosses indicate data censoring